Search details
1.
Inflammasome Activation Triggers Blood Clotting and Host Death through Pyroptosis.
Immunity
; 50(6): 1401-1411.e4, 2019 06 18.
Article
in English
| MEDLINE | ID: mdl-31076358
2.
Ribosomal protein S3 mediates drug resistance of proteasome inhibitor: potential therapeutic application in multiple myeloma.
Haematologica
; 109(4): 1206-1219, 2024 Apr 01.
Article
in English
| MEDLINE | ID: mdl-37767568
3.
Dihydrocelastrol induces cell death and suppresses angiogenesis through BCR/AP-1/junb signalling in diffuse large B cell lymphoma.
Arch Biochem Biophys
; 754: 109929, 2024 Apr.
Article
in English
| MEDLINE | ID: mdl-38367794
4.
Design and synthesis of cantharidin derivative DCZ5418 as a TRIP13 inhibitor with anti-multiple myeloma activity in vitro and in vivo.
Bioorg Med Chem Lett
; 98: 129590, 2024 Jan 15.
Article
in English
| MEDLINE | ID: mdl-38092072
5.
EZH2 inhibition induces senescence via ERK1/2 signaling pathway in multiple myeloma.
Acta Biochim Biophys Sin (Shanghai)
; 2024 May 27.
Article
in English
| MEDLINE | ID: mdl-38804044
6.
The novel norcantharidin derivative DCZ5417 suppresses multiple myeloma progression by targeting the TRIP13-MAPK-YWHAE signaling pathway.
J Transl Med
; 21(1): 858, 2023 11 27.
Article
in English
| MEDLINE | ID: mdl-38012658
7.
Molecular mechanism by which RRM2-inhibitor (cholagogue osalmid) plus bafilomycin A1 cause autophagic cell death in multiple myeloma.
Arch Biochem Biophys
; 747: 109771, 2023 Oct 01.
Article
in English
| MEDLINE | ID: mdl-37776936
8.
A novel alkaloid compound, DCZ0358, exerts significant antitumor activity in bortezomib-resistant multiple myeloma cells through inhibition of JAK2/STAT3 pathway.
Acta Biochim Biophys Sin (Shanghai)
; 55(2): 215-224, 2023 Feb 25.
Article
in English
| MEDLINE | ID: mdl-36815376
9.
Dihydrocelastrol induces antitumor activity and enhances the sensitivity of bortezomib in resistant multiple myeloma by inhibiting STAT3-dependent PSMB5 regulation.
Acta Biochim Biophys Sin (Shanghai)
; 55(12): 1884-1891, 2023 12 25.
Article
in English
| MEDLINE | ID: mdl-38009004
10.
Preclinical validation and phase I trial of 4-hydroxysalicylanilide, targeting ribonucleotide reductase mediated dNTP synthesis in multiple myeloma.
J Biomed Sci
; 29(1): 32, 2022 May 12.
Article
in English
| MEDLINE | ID: mdl-35546402
11.
A novel phosphoramide compound, DCZ0805, shows potent anti-myeloma activity via the NF-κB pathway.
Cancer Cell Int
; 21(1): 285, 2021 May 30.
Article
in English
| MEDLINE | ID: mdl-34053438
12.
Anti-DLBCL efficacy of DCZ0825 in vitro and in vivo: involvement of the PI3KâAKTâmTOR/JNK pathway.
Acta Biochim Biophys Sin (Shanghai)
; 53(5): 575-583, 2021 Apr 15.
Article
in English
| MEDLINE | ID: mdl-33821934
13.
Quercetin inhibits the proliferation of multiple myeloma cells by upregulating PTPRR expression.
Acta Biochim Biophys Sin (Shanghai)
; 53(11): 1505-1515, 2021 Nov 10.
Article
in English
| MEDLINE | ID: mdl-34558606
14.
Resveratrol induces AMPK and mTOR signaling inhibition-mediated autophagy and apoptosis in multiple myeloma cells.
Acta Biochim Biophys Sin (Shanghai)
; 53(6): 775-783, 2021 May 21.
Article
in English
| MEDLINE | ID: mdl-33891090
15.
Novel cyclophosphamide of natural products osalmide and pterostilbene induces cytotoxicity and cell cycle arrest in diffuse large B-cell lymphoma cells.
Acta Biochim Biophys Sin (Shanghai)
; 52(4): 401-410, 2020 Apr 20.
Article
in English
| MEDLINE | ID: mdl-32259210
16.
DCZ0801, a novel compound, induces cell apoptosis and cell cycle arrest via MAPK pathway in multiple myeloma.
Acta Biochim Biophys Sin (Shanghai)
; 51(5): 517-523, 2019 May 23.
Article
in English
| MEDLINE | ID: mdl-30947332
17.
DCZ3301, a novel aryl-guanidino inhibitor, induces cell apoptosis and cell cycle arrest via suppressing the PI3K/AKT pathway in T-cell leukemia/lymphoma.
Acta Biochim Biophys Sin (Shanghai)
; 50(7): 643-650, 2018 Jul 01.
Article
in English
| MEDLINE | ID: mdl-29688264
18.
Targeting the PI3K/Akt/mTOR signaling pathway by pterostilbene attenuates mantle cell lymphoma progression.
Acta Biochim Biophys Sin (Shanghai)
; 50(8): 782-792, 2018 Aug 01.
Article
in English
| MEDLINE | ID: mdl-29961897
19.
PKC inhibition of sotrastaurin has antitumor activity in diffuse large B-cell lymphoma via regulating the expression of MCT-1.
Acta Biochim Biophys Sin (Shanghai)
; 50(4): 399-407, 2018 Apr 01.
Article
in English
| MEDLINE | ID: mdl-29534146
20.
Dihydrocelastrol inhibits multiple myeloma cell proliferation and promotes apoptosis through ERK1/2 and IL-6/STAT3 pathways in vitro and in vivo.
Acta Biochim Biophys Sin (Shanghai)
; 49(5): 420-427, 2017 May 01.
Article
in English
| MEDLINE | ID: mdl-28338993